Physician profile
Issa Rezek
NPI 1730507427
$8,582.51
in general payments reported to CMS, 2019-2025
10 companies · $888 in 2025
The $888 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $6,797 · 2022: $22.92 · 2023: $664 · 2024: $78.00 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $885 · Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $884.79 |
| Food and Beverage | $745.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,275.47 | 2021-2025 | |
| Edwards Lifesciences Corporation | $497.79 | 2021-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $435.96 | 2021 | |
| Terumo Bct, INC. | $132.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $93.84 | 2021 | |
| Medtronic, INC. | $78.00 | 2024 | Corevalve Evolut R |
| Davol INC. | $28.92 | 2021 | |
| Merck Sharp & Dohme LLC | $15.83 | 2025 | Verquvo |
| Kci USA, INC. | $15.08 | 2023 | V.A.C. Veraflo, Prevena |
| Kls-Martin L.P. | $9.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Issa Rezek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.